Drug firm Novartis India today said its net profit declined by 8.89% to Rs 39.34 crore for the quarter ended September 30, 2012 over the same period last fiscal.
The company had posted a net profit of Rs 43.18 crore for the quarter ended September 30, 2011, Novartis India said in a statement.
Net sales of the company, however, rose to Rs 237.43 crore for the quarter under consideration from Rs 218.97 crore for the corresponding period previous fiscal.
Novartis India is a part of pharma major Novartis. The Switzerland headquartered firm has core businesses in pharmaceuticals, vaccines, consumer health, generics, eye care and animal health.
Shares of Novartis India today closed at Rs 687.10 per scrip on BSE, up 1.82% from its previous close.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app